Answers (1)
Official Answer by Drugs.com
5 Jul 2017
Imfinzi (durvalumab) is a cancer medicine that works with your immune system to slow cancer cell growth. Imfinzi is classified as an anti-PD-L1 (programmed death ligand-1) human monoclonal antibody. In May 2017, Imfinzi was given FDA-approval for the treatment of patients with advanced urothelial carcinoma (bladder cancer) who have disease progression despite use of platinum-containing chemotherapy with or without surgery.
Further Information
- Imfinzi Information for Consumers
- Imfinzi Information for Healthcare Professionals (includes dosage details)
- Side Effects of Imfinzi (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Frequently Asked Questions
What type of drug is Motegrity?
Updated 16 days ago • 1 answerFAQ by Drugs.com
How does Asparlas (calaspargase pegol-mknl) compare to Oncaspar (pegaspargase)?
Updated 13 days ago • 1 answerFAQ by Drugs.com
What disease is Elzonris (tagraxofusp-erzs) used to treat?
Updated 13 days ago • 1 answerFAQ by Drugs.com
How do you use the ProAir Digihaler?
Updated 13 days ago • 1 answerFAQ by Drugs.com
How many biosimilars have been approved in the United States?
Updated 12 days ago • 1 answerFAQ by Drugs.com
